Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Exelixis Q2 2025 Earnings Call - Strong CABOMETYX Momentum and Positive Zanzalintinib Data Propel Growth
Exelixis reported robust Q2 2025 results marked by a 19% year-over-year increase in CABOMETYX U.S. revenues to $520 million, driven by strong demand and the promising launch of the neuroendocrine tumo...
- CABOMETYX U.S. franchise net product revenue grew 19% year over year to $520 million in Q2 2025.
- Neuroendocrine tumor (NET) indication launch for CABOMETYX contributed over 4% of Q2 revenue, rapidly gaining approximately 35% new patient market share in second-line plus oral segment.
- CABOMETYX remains the leading tyrosine kinase inhibitor (TKI) for renal cell carcinoma (RCC) and number one TKI plus immune-oncology (IO) combination in first-line RCC.
- +9 more takeaways
Stanley Black & Decker 2025 Q2 Earnings Call - Navigating Tariff Turbulence While Advancing Supply Chain Transformation
Stanley Black & Decker's Q2 2025 results reveal a company grappling with tariff-induced headwinds and a sluggish outdoor buying season, yet focused on executing a robust supply chain transformation. R...
- Stanley Black & Decker's Q2 2025 revenue declined 2% to $3.9 billion, with organic revenue down 3%, primarily due to slow outdoor buying and tariff-related shipment disruptions.
- DeWalt brand showed consistent growth across product lines and regions, supported by investments in innovation and marketing, sustaining over two years of growth.
- Gross margin dropped to 27.5% in Q2 due to a three-point tariff impact and lower volume, but supply chain efficiencies and pricing partially offset the decline.
- +7 more takeaways
Spotify Q2 2025 Earnings Call - Surpassing User Growth Amidst Advertising Execution Challenges
Spotify reported a strong Q2 2025 with robust user and subscriber growth, hitting over 100 million subscribers in Europe and exceeding guidance for monthly active users and subscribers. The company's ...
- Spotify exceeded guidance with 696 million monthly active users and 276 million subscribers, marking 12% year-over-year subscriber growth.
- Europe surpassed 100 million subscribers, the largest regional milestone for Spotify.
- Total revenue grew 15% year-over-year on a constant currency basis to EUR 4.2 billion, with premium revenue up 16%.
- +12 more takeaways
Johnson Controls Q3 2025 Earnings Call - Strong Organic Growth and Focused Business System Implementation Drive Momentum
Johnson Controls reported a robust Q3 2025 with 6% organic sales growth, 20 basis points margin expansion to 17.6%, and 11% adjusted EPS growth beating guidance. CEO Joakim Weidemanis, 140 days into h...
- Organic sales grew 6% in Q3 2025, with segment margins expanding 20 basis points to 17.6%
- Adjusted EPS rose 11%, beating the high end of company guidance
- Year-to-date adjusted free cash flow nearly doubled to $1.8 billion, driving over 100% free cash flow conversion for the year
- +7 more takeaways
LATAM Airlines Group 2Q2025 Earnings Call - Strong Operational Growth and Record Profitability Amid Market Stability
LATAM Airlines Group showcased robust growth and operational resilience in the second quarter of 2025, transporting over 20.5 million passengers—a 7.6% increase year-over-year—and achieving a consolid...
- LATAM Airlines Group transported over 20.5 million passengers in 2Q2025, marking a 7.6% year-over-year increase.
- Consolidated capacity grew 8.3%, with Brazil's domestic market expanding 10.9% and international capacity up 9.6%.
- Consolidated load factor improved to 83.5%, up 1.2 percentage points year-over-year, reflecting strong demand.
- +13 more takeaways
Electronic Arts Q1 FY2026 Earnings Call - Strong Start with Strategic Focus on Massive Online Communities and Upcoming Launches
Electronic Arts kicked off fiscal year 2026 on a high note, exceeding guidance with $1.3 billion in net bookings, boosted by global football, apex legends, and Star Wars franchises. The company is rid...
- Q1 FY2026 net bookings reached $1.3 billion, up 3% year over year, surpassing the high end of guidance.
- Global Football franchise delivered mid-single-digit net bookings growth, powered by FC Mobile's record quarter with over 50 million installs and strong DAU expansion.
- EA Sports released College Football 26 to strong reviews and competitive retention, setting it up as a core franchise despite expectation for normalization after 2025's pent-up demand peak.
- +7 more takeaways
Telefónica 2Q 2025 Earnings Call - Strategic Review Underway Amid Steady Execution and Market Reshaping
Telefónica's second-quarter 2025 earnings preview a company in methodical transition. CEO Marc Murtra emphasized steady operational momentum, strategic portfolio streamlining in Latin America with €3 ...
- CEO Marc Murtra highlights progress on strategic review, aiming for an H2 reveal of plans to unlock company value.
- Telefónica achieved 2 million net accesses added in Q2, totaling 349 million, with strong customer satisfaction and low churn.
- Spain completed full copper network shutdown, the first major European operator to do so, realizing over 1% EBITDA margin benefit in 2024.
- +12 more takeaways
Teva Pharmaceutical Industries Q2 2025 Earnings Call - Innovative Portfolio Drives 10th Consecutive Quarter of Growth
Teva Pharmaceutical Industries reported its tenth straight quarter of growth with Q2 2025 revenues reaching $4.2 billion, up 1%, fueled by a rapidly expanding innovative portfolio including Austedo, A...
- Q2 2025 revenues grew 1% to $4.2 billion, marking 10 consecutive quarters of growth driven by innovative products.
- Innovative portfolio products Austedo, Ajovy, and Eucedi showed strong growth, with Austedo up 19%, Ajovy up 31%, and Eucedi surging 120%.
- Guidance for 2025 revenues for Austedo, Ajovy, and Eucedi combined increased by approximately $100 million at midpoint.
- +7 more takeaways
Unum Group Q2 2025 Earnings Call - Navigating Elevated Claims and Resetting Growth Expectations
Unum Group's Q2 2025 results fell short of initial expectations primarily due to higher-than-anticipated claims, especially in group disability and long-term care (LTC). Despite a notable earnings sho...
- Q2 GAAP earnings missed expectations due to higher claim costs, notably in group disability and LTC.
- Core premium growth sustained near 5%, supported by strong persistency and payroll/wage inflation.
- Group disability benefit ratio rose to 62%, higher than planned but still delivering ROE above 25%.
- +13 more takeaways
Humana 2Q 2025 Earnings Call - Raising Full Year EPS Outlook on Membership and Pharmacy Strength
Humana reported solid second quarter performance with outperformance driven by CenterWell Pharmacy and stronger-than-expected individual Medicare Advantage membership. Medical cost trends aligned with...
- Humana raised full year 2025 adjusted EPS outlook from approx. $16.25 to $17 based on Q2 and H1 performance.
- Individual MA membership decline improved to 500,000 vs. prior 550,000 estimate; bounce-back members returning during OEP and ROI.
- CenterWell Pharmacy outperformed driven by higher direct-to-consumer volume and favorable specialty pharmacy drug mix.
- +14 more takeaways